|
Solvent |
mg/mL |
mM |
| Solubility |
| Soluble in DMSO |
0.0 |
100.00 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
1,331.78
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kwon YJ, Kim HJ, Kim WG. Complestatin exerts antibacterial activity by the inhibition of fatty acid synthesis. Biol Pharm Bull. 2015;38(5):715-21. doi: 10.1248/bpb.b14-00824. PMID: 25947917.
2: Culp EJ, Waglechner N, Wang W, Fiebig-Comyn AA, Hsu YP, Koteva K, Sychantha D, Coombes BK, Van Nieuwenhze MS, Brun YV, Wright GD. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature. 2020 Feb;578(7796):582-587. doi: 10.1038/s41586-020-1990-9. Epub 2020 Feb 12. PMID: 32051588.
3: Kim EC, Yun BS, Ryoo IJ, Min JK, Won MH, Lee KS, Kim YM, Yoo I-, Kwon YG. Complestatin prevents apoptotic cell death: inhibition of a mitochondrial caspase pathway through AKT/PKB activation. Biochem Biophys Res Commun. 2004 Jan 2;313(1):193-204. doi: 10.1016/j.bbrc.2003.11.104. PMID: 14672717.
4: Seo SY, Yun BS, Ryoo IJ, Choi JS, Joo CK, Chang SY, Chung JM, Oh S, Gwag BJ, Yoo ID. Complestatin is a noncompetitive peptide antagonist of N-methyl-D- aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death. J Pharmacol Exp Ther. 2001 Oct;299(1):377-84. PMID: 11561102.
5: Breazzano SP, Boger DL. Synthesis and stereochemical determination of complestatin A and B (neuroprotectin A and B). J Am Chem Soc. 2011 Nov 16;133(45):18495-502. doi: 10.1021/ja208570q. Epub 2011 Oct 20. PMID: 21991993; PMCID: PMC3217038.
6: Yamada Y, Akiba A, Arima S, Okada C, Yoshida K, Itou F, Kai T, Satou T, Takeda K, Harigaya Y. Synthesis of linear tripeptides for right-hand segments of complestatin. Chem Pharm Bull (Tokyo). 2005 Oct;53(10):1277-90. doi: 10.1248/cpb.53.1277. PMID: 16204984.
7: Kaneko I, Kamoshida K, Takahashi S. Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization. J Antibiot (Tokyo). 1989 Feb;42(2):236-41. doi: 10.7164/antibiotics.42.236. PMID: 2925515.
8: Wang Z, Bois-Choussy M, Jia Y, Zhu J. Total synthesis of complestatin (chloropeptin II). Angew Chem Int Ed Engl. 2010 Mar 8;49(11):2018-22. doi: 10.1002/anie.200906797. PMID: 20148426.
9: Park OK, Choi HY, Kim GW, Kim WG. Generation of New Complestatin Analogues by Heterologous Expression of the Complestatin Biosynthetic Gene Cluster from Streptomyces chartreusis AN1542. Chembiochem. 2016 Sep 15;17(18):1725-31. doi: 10.1002/cbic.201600241. Epub 2016 Aug 2. PMID: 27383040.
10: Yoo ID, Yun B, Ryoo IJ, Lee SY, Shin MH, Oh S. Complestatin antagonizes the AMPA/kainate-induced neurotoxicity in cultured chick telencephalic neurons. Neurochem Res. 2002 Apr;27(4):337-43. doi: 10.1023/a:1014919531306. PMID: 11958537.
